We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

82 hedge funds and large institutions have $790M invested in Avidity Biosciences in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

53% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 15

22% more funds holding

Funds holding: 67 → 82 (+15)

10.5% more ownership

Funds ownership: 72% → 82.5% (+11%)

5% more capital invested

Capital invested by funds: $755M → $790M (+$34.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
82
Holders Change
+15
Holders Change %
+22.39%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
23
Reduced
15
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Alethea Capital Management
Washington
+$45.8M
2
BlackRock
BlackRock
New York
+$21.4M
3
State Street
State Street
Massachusetts
+$12.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.8M
5
TG
TCW Group
California
+$5.34M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$11M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.03M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.08M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.2M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$2.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.91M -$35.1K -1,204 -0.6%
TG
27
TCW Group
California
$4.67M +$5.34M +183,081 New
AG
28
Artal Group
Luxembourg
$3.64M – – –
WP
29
Woodline Partners
California
$3.27M -$1.31M -44,978 -26%
Deutsche Bank
30
Deutsche Bank
Germany
$2.87M +$97.6K +3,348 +3%
Charles Schwab
31
Charles Schwab
California
$2.8M +$56.4K +1,935 +2%
Millennium Management
32
Millennium Management
New York
$2.66M +$3.04M +104,216 New
Wells Fargo
33
Wells Fargo
California
$2.06M +$804K +27,557 +52%
Morgan Stanley
34
Morgan Stanley
New York
$1.72M +$1.81M +62,178 +1,232%
N
35
Nuveen
North Carolina
$1.66M +$6.15K +211 +0.3%
Los Angeles Capital Management
36
Los Angeles Capital Management
California
$1.65M +$1.88M +64,538 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.61M +$485K +16,639 +36%
SSA
38
Schonfeld Strategic Advisors
New York
$1.25M +$1.43M +49,110 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$825K -$17.5K -600 -2%
HLA
40
Hamilton Lane Advisors
Pennsylvania
$802K +$917K +31,442 New
Swiss National Bank
41
Swiss National Bank
Switzerland
$758K +$866K +29,700 New
HS
42
HighVista Strategies
Massachusetts
$680K +$276K +9,463 +55%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$646K – – –
CS
44
Credit Suisse
Switzerland
$642K +$734K +25,180 New
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$602K +$688K +23,600 New
TD Asset Management
46
TD Asset Management
Ontario, Canada
$592K +$46.7K +1,600 +7%
Principal Financial Group
47
Principal Financial Group
Iowa
$556K +$635K +21,768 New
CS
48
Candriam SCA
Luxembourg
$498K -$14.7K -503 -3%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$493K +$52.4K +1,796 +10%
JMPWA
50
JP Morgan Private Wealth Advisors
California
$482K +$551K +18,900 New
1
2
3 4

RNAM Hedge Fund Activity: Q4 2020 in Review

82 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q4 2020, worth a combined $790M — up 4.6% from $755M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RNAM positions and 14 closed out — a net gain of 15 holders — while 23 added to existing stakes and 15 trimmed.

The largest buyer was Alethea Capital Management, opening a new position worth an estimated $45.8M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $11M sold.

  • 82 institutional investors held Avidity Biosciences (RNAM) as of Q4 2020, up from 67 in Q3 2020.
  • Funds reported $790M of Avidity Biosciences stock for Q4 2020, up 4.6% quarter-over-quarter.
  • 29 funds opened new Avidity Biosciences positions in Q4 2020 and 14 closed out, a net change of +15 holders.
  • The largest Avidity Biosciences buyer in Q4 2020 was Alethea Capital Management, an estimated $45.8M added.
  • The largest Avidity Biosciences seller in Q4 2020 was PFM Health Sciences, an estimated $11M sold.

Based on aggregated 13F filings for Q4 2020.